|
業務類別
|
Biotechnology |
|
業務概覽
|
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis. |
| 公司地址
| 490 Arsenal Way, Suite 210, Watertown, MA, USA, 02472 |
| 電話號碼
| +1 339 666-3320 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.tectonictx.com |
| 員工數量
| 60 |
| Dr. Peter McNamara, PhD |
Chief Scientific Officer |
-- |
25/04/2025 |
| Dr. Alise S. Reicin, M.D. |
President, Chief Executive Officer and Director |
美元 606.15K |
26/02/2026 |
| Mr. Daniel Lochner, M.B.A. |
Chief Financial Officer and Principal Accounting Officer |
美元 277.08K |
26/02/2026 |
| Dr. Marcella Kuhlman Ruddy, M.D.,M.S. |
Chief Medical Officer |
美元 476.17K |
25/04/2025 |
| Dr. Marc Schwabish, PhD |
Chief Business Officer |
-- |
25/04/2025 |
|
|
| Mr. Phillip B. Donenberg |
Independent Director |
26/02/2026 |
| Dr. Timothy A. Springer, M.D.,PhD |
Independent Director |
26/02/2026 |
| Dr. Francois Nader,M.D. |
Chairman of the Board |
24/02/2026 |
| Dr. Alise S. Reicin, M.D. |
President, Chief Executive Officer and Director |
26/02/2026 |
| Mr. Stefan Vitorovic, M.B.A.,M.S. |
Independent Director |
26/02/2026 |
| Mr. Terrance McGuire, M.B.A.,M.S. |
Independent Director |
24/02/2026 |
| Dr. Praveen Tipirneni, M.B.A.,M.D. |
Independent Director |
26/02/2026 |
|
|
|
|
